A UCSF research team led by Department of Bioengineering and Therapeutic Sciences Chair and Professor James Fraser, PhD and Department of Pharmaceutical Chemistry Professor William DeGrado, PhD, has pioneered a breakthrough approach to designing proteins with targeted functions, which could lead to simpler ways to improve enzymes and medications, among other uses, according to a new study published in Nature Chemistry.
Seven forward-thinking projects poised to advance the mission of the UCSF School of Pharmacy have been selected to receive support through the 2026 Mary Anne Koda-Kimble Seed Award for Innovation.
Rada Savic, PhD, has been awarded a $30.6M grant over five years from the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) for a cooperative agreement establishing a global consortium of tuberculosis (TB) preclinical and clinical experts to research the most effective treatment and testing options.
Su Guo, PhD, professor in the Department of Bioengineering and Therapeutic Sciences, is seeking to expand our understanding of the brain to help treat neuropsychiatric disorders.
From designing smarter tuberculosis treatments to engineering new therapeutic proteins and decoding the genetic basis of disease, research at the UCSF School of Pharmacy is improving patient care and advancing medicine worldwide.
Department of Bioengineering and Therapeutic Sciences Professor Shuvo Roy, PhD, is advancing The Kidney Project toward clinical readiness while translating its filtration technology into new therapies that could transform treatment for kidney failure, blood safety, neonatal care, and diabetes.
More than 100 current and former graduate students gathered on Oct. 3 for the School of Pharmacy’s first “Bridging Past and Future: Highlighting UCSF Graduate Students and Alumni” symposium.
Population geneticist Ryan Hernandez, PhD, a professor in the Department of Bioengineering and Therapeutic Sciences, is recognized for revealing how humanity’s shared continuum shapes health outcomes and for expanding opportunities for aspiring scientists.
Vice Dean of Research Tanja Kortemme, PhD, and Department of Bioengineering and Therapeutic Sciences Assistant Professor Kyle Cromer, PhD, are among seven UCSF scientists recognized with prestigious NIH High-Risk, High-Reward Awards for 2025.
By dialing up a healthy gene, Department of Bioengineering and Therapeutic Sciences Professor Nadav Ahituv, PhD and a team of UCSF scientists stopped seizures in mice with a common mutation found in neurodevelopmental disorders like epilepsy and autism.
Fraser and his research team uses synchrotron X-rays to reveal enzyme targets and revive antibiotics that are losing effectiveness against resistant bacteria.
A new initiative led by the school's Quantitative Biosciences Institute will support mentorship and research capacity, platforms for knowledge exchange, and an international exchange program for promising early-career African scientists.
The staff awardees include individuals in many different roles and functions across the school.
Department of Bioengineering and Therapeutic Sciences Professor Tanja Kortemme, PhD, offers insight into how federally-funded research has America on the cusp of a new dawn in pharmaceuticals, offering hope for curing the most heartbreaking diseases.
Department of Bioengineering and Therapeutic Sciences Professor Joanne Chun, PharmD ’93, PhD ’96 leads the MS in AICD3 program — the first of its kind in the nation focused on AI’s transformation of drug discovery and development. Learn more about how AI-based research benefit patients and how the program is developing leaders who can think across disciplines.